Deep Lens, a digital pathology startup particularly focused on cancer trials, has brought in a $13.65 million Series A round, according to an SEC filing. The fundraise was headed by Northpond Ventures with additional support from prior investors Rev1 Ventures, Sierra Ventures and Tamarind-Hill Partners, according to a release.
The Series A comes quickly after a seed funding round that raised just...
Columbus, Ohio-based Deep Lens, a digital pathology startup out of Nationwide Children’s Hospital focused on cancer clinical trials, has raised $3.2 million in seed funding. Sierra Ventures led the round with participation from Rev1 Ventures and Tamarin Hill Fund.
With digital pathology, rather than examining a bio specimen with a microscope, a pathologist can study a large number of digitized...
